These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11132728)

  • 61. Psoralens and related compounds in the treatment of psoriasis.
    McEvoy MT; Stern RS
    Pharmacol Ther; 1987; 34(1):75-97. PubMed ID: 3310045
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [DNA-repair of lymphocytes during PUVA-treatment (author's transl)].
    Bohnert E; Humbel WG
    Arch Dermatol Res; 1980; 267(2):175-8. PubMed ID: 6893264
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recent advances in PUVA photochemotherapy and PDT for the treatment of cancer.
    Nagy EM; Dalla Via L; Ronconi L; Fregona D
    Curr Pharm Des; 2010 Jun; 16(16):1863-76. PubMed ID: 20337576
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Trimethylpsoralen bath plus ultraviolet A combined with oral retinoid (etretinate) in the treatment of severe psoriasis.
    Väätäinen N; Hollmen A; Fräki JE
    J Am Acad Dermatol; 1985 Jan; 12(1 Pt 1):52-5. PubMed ID: 3980803
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Elastic tissue changes in skin following PUVA therapy.
    Zelickson AS; Mottaz JH; Zelickson BD; Muller SA
    J Am Acad Dermatol; 1980 Aug; 3(2):186-92. PubMed ID: 6893335
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Position paper--PUVA therapy. American Academy of Dermatology.
    Bickers DR
    J Am Acad Dermatol; 1983 Feb; 8(2):265-70. PubMed ID: 6402528
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Trioxsalen baths plus UV-A in the treatment of lichen planus and urticaria pigmentosa.
    Väätäinen N; Hannuksela M; Karvonen J
    Clin Exp Dermatol; 1981 Mar; 6(2):133-8. PubMed ID: 7261467
    [No Abstract]   [Full Text] [Related]  

  • 68. Ineffectiveness of aprotinin on psoralen-UVA-(PUVA)-induced erythema.
    Weintraub E; West DP; Solomon LM
    J Invest Dermatol; 1979 Dec; 73(6):527-9. PubMed ID: 315976
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Burns caused by accidental overdose of photochemotherapy (PUVA).
    Herr H; Cho HJ; Yu S
    Burns; 2007 May; 33(3):372-5. PubMed ID: 17218059
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of PUVA on a human skin epithelial cell line.
    Johnsen AS; Digernes V; Rugstad HE
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1981; 37(1):61-9. PubMed ID: 6116349
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A mathematical model of the biologically effective dose of solar UVA received by patients undergoing oral psoralen photochemotherapy for psoriasis.
    Diffey BL
    Phys Med Biol; 1981 Nov; 26(6):1129-35. PubMed ID: 7323150
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Studies on the PUVA (psoralen plus UVA) therapy of psoriasis. II. Histological findings of the treated skin (author's transl)].
    Kumakiri M; Ohnuki M; Koguchi K; Kato N; Tachibana N; Miura Y
    Nihon Hifuka Gakkai Zasshi; 1980 Oct; 90(11):1003-8. PubMed ID: 6970278
    [No Abstract]   [Full Text] [Related]  

  • 73. Ocular complications of PUVA therapy.
    See JA; Weller P
    Australas J Dermatol; 1993; 34(1):1-4. PubMed ID: 8240180
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study).
    Saïd A; Makki S; Muret P; Humbert P; Millet J
    J Dermatol Sci; 1997 Feb; 14(2):136-44. PubMed ID: 9039977
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Photochemotherapy beyond psoriasis.
    Honig B; Morison WL; Karp D
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):775-90. PubMed ID: 7929924
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Present aspects concerning the molecular mechanisms of photochemotherapy with psoralens.
    Rodighiero G; Dall'Acqua F
    Drugs Exp Clin Res; 1986; 12(6-7):507-15. PubMed ID: 3527629
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The lack of efficacy of 4,6,6'-trimethylangelicin to induce immune suppression in an animal model for photopheresis: a comparison with 8-MOP.
    van Iperen HP; Brun BM; Caffieri S; Dall'Acqua F; Gasparro FP; Beijersbergen Henegouwen GM
    Photochem Photobiol; 1996 May; 63(5):577-82. PubMed ID: 8628748
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Activation of the human immunodeficiency virus promoter by UVA radiation in combination with psoralens or angelicins.
    Zmudzka BZ; Strickland AG; Miller SA; Valerie K; Dall'Acqua F; Beer JZ
    Photochem Photobiol; 1993 Aug; 58(2):226-32. PubMed ID: 8415914
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The contribution of medical physics to the development of psoralen photochemotherapy (PUVA) in the UK: a personal reminiscence.
    Diffey B
    Phys Med Biol; 2006 Jul; 51(13):R229-44. PubMed ID: 16790905
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Psoralen binding and inhibition of epidermal growth factor binding by psoralen/ultraviolet light (PUVA) in human epithelial cells.
    Laskin JD; Lee E
    Biochem Pharmacol; 1991 Jan; 41(1):125-32. PubMed ID: 1846071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.